Enacts the manufacturer disclosure and transparency act
Summary
Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2021
Committee Review
Floor Vote
Governor
Introduced Jan 6, 2021
Last action Jan 5, 2022
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
2
Jan 5, 2022
Committee
REFERRED TO CONSUMER PROTECTION
upper
Jan 6, 2021
Committee
REFERRED TO CONSUMER PROTECTION
upper
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
AB
Alessandra Biaggi
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about S 398
Scope: NY
Hi! I can help you understand S 398. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline